[DOCUMENT TITLE]
[Document subtitle]
[DATE]
[COMPANY NAME]
[Company address]
Table of Contents
Part A: Individual Simulation Evaluation (Business Simulation).................................................................1
2. Describe the simulation company Vision and Strategy over the simulation..........................................................1
3 Important Decisions Made........................................................................................................................................3
4 Performance Analysis Quarterly Results..................................................................................................5
5. Future Company Strategy......................................................................................................................9
Part B: Individual Reflective Report (Professional Development)..................................................................11
Introduction...................................................................................................................................................11
Application of Theory and Practice..........................................................................................................13
Strategic Investment in R&D...........................................................................................................................13
Market Expansion Strategy.................................................................................................................14
Theory Application....................................................................................................................14
Appendix..............................................................................................................................18
References..........................................................................................................................19
increased revenue over the next fiscal year are the results of our decision to raise R&D expenditure
by 20% to €60 million. This move has also sped development and product development. The goal
of market expansion has been to reach the €500 billion target market size in developing markets.
Our objective is to attain a 15% market share in the upcoming year by strategically allocating
resources, which includes allocating €30 million for market entrance tactics. This will position us
for long-term growth and market penetration. Operational efficiency has been a major area of
attention, with projects like automation in shipping and manufacturing helping to reduce operating
costs by 10%, which is expected to save €20 million annually. Furthermore, it is anticipated that
€25 million invested in digital transformation initiatives would improve supply chain
responsiveness and visibility, resulting in 15% shorter lead times and 5% more on-time
deliveries(Hughes,2015).
2. Describe the simulation company Vision and Strategy over the simulation
The GSK company's purpose, seeing, and HR policies are reflected into its strategy and goals,
which are designed to support its overriding objective of fostering beneficial and long-term
development. a summary of a thorough explanation:
Vision
The GSK firm is to use innovative technologies, encourage creativity, and support
environmentally friendly procedures to transform the industry. GSK wants to be an innovator in
providing top-notch goods and services that improve the lives of others and benefit the natural
world and community (Van der Merwe,2013).
Values
The core values of the GSK organization are honesty, quality, teamwork, and social responsibility.
Its acts are guided by truthfulness, which guarantees openness, truthfulness, and moral behavior
in all dealings.
Mission
The goal is to create value for our stakeholders by offering creative solutions to urgent problems. the dedication is in providing exceptional goods and services that surpass customer expectations,
augment shareholder value, foster employee growth and welfare, and have a constructive impact
on the communities where we do business.
HR Policies
The Human Resources guidelines are intended to support an inclusive, growth-oriented, and
learning culture while drawing in and developing elite talent. giving top priority to the growth,
well-being, competitive compensation, and generous advantages offered to employees.
The goal of the company's mission and strategy is to create sustainable growth and a positive effect
in the industry and beyond via innovation, honesty and teamwork, social responsibility, for the
well-being of staff members.
3. Competition Analysis
Market Choice/Share
It looked at market niches to find areas for expansion. It concentrated on industries with significant
growth potential, such cancer and respiratory/immunology, where GlaxoSmithKline (GSK) has
robust solutions, based on evidence.
Competitors
Important rivals such as Pfizer, AstraZeneca, and Johnson & Johnson were included in the
research. To determine their competitive advantages and disadvantages, they evaluated their
market share, product lines, and tactical choices (Van der Merwe, 2013).
Internal Capabilities
I assessed GSK's internal strengths, including its manufacturing capacity, distribution networks,
and R&D skills. This enabled them to pinpoint both GSK's competitive advantages and areas in
need of development.
3
3 Important Decisions Made
Important Decisions Made
Investment Focus
Strategic Partnerships
Market Expansion
Investment Focus
It made the decision to focus investments in areas where GSK may obtain a competitive advantage,
such as quickening clinical trials for promising cures and increasing manufacturing capacity for
highly sought-after products, based on the competition analysis.
Strategic Partnerships
To improve the pipeline and gain access to cutting-edge technology, they formed strategic
alliances with academic institutions and biotech businesses(Hughes,2015)..
Market Expansion
It establish goals to increase market share in important therapeutic areas through the introduction
of new goods, forays into untapped markets, and fortifying ties with healthcare professionals.
4
Quarterly Targets
Quarterly Targets
Q1-Q4 Revenue Growth
Achieving a 5% revenue rise every quarter, propelled by heightened sales in strategic areas and triumphant product releases, was one of the quarterly objectives.
Market Share Increase
By the end of the year, it wanted to have increased our market share by 2% in the cancer and respiratory/immunology areas through competitive pricing and targeted marketing initiatives.
Cost Optimization
The objectives are to increase production and supply chain process efficiency by 3% per quarter in order to lower operating expenses.
By carefully coordinating the work in with thorough market research, it put GSK in a position to make wise and practical investment choices, focusing on wise resource management and tactical alliances strengthened the internal capacities and increased the competitive advantage.
The thorough examination of competition tactics, market choice/share, and our own advantages allowed us to pinpoint important opportunities for expansion and distinction.
The most important choices were to optimize the product range to satisfy changing market demands and to prioritize R&D spending in high-potential therapeutic areas.
In order to ensure financial sustainability and guarantee ongoing progress towards our long-term goals, quarterly milestones were set with a balance of ambition and realism. This strategy was to promote long-term growth and value generation for stakeholders in addition to strengthening our position as a leader in the industry (Hughes,2015)..
4 Performance Analysis Quarterly Results
Position
The term "position" describes how the business is positioned in the market in relation to its rivals and its goals. It consists of competitive advantage, market share, and what customers think.
Quarter Market Share (%) Customer Perception Competitive Advantage
Q1 2023 20% Positive Innovative Products
Q2 2023 18% Neutral Cost Leadership
Q3 2023 21% Positive Strong Brand Image
Q4 2023 19% Negative Product Quality
Analysis
Through the year, the firm remained competitive, with variations in market share resulting from marketing tactics and product excellence. Due to creative items and a strong brand image, consumer sentiment increased in Q1 and Q3, but it decreased in Q4 as a result of quality problems.
Key Performance Indicators (KPIs)
KPI Target Actual (Q1) Actual (Q2) Actual (Q3) Actual (Q4)
Revenue Growth (%) 10% 12% 9% 11% 7%
Customer Satisfaction (1-5) 4.5 4.8 4.6 4.7 4.2
Cost of Goods Sold (COGS) £10M £9.5M £10.2M £9.8M £11M
Employee Turnover (%) 8% 6% 7% 5% 9%
Financial Performance
Quarter Revenue (£M) Operating Profit (£M) Net Profit (£M) Earnings per Share (p)
Q1 2023 £100M £20M £15M 30p
Q2 2023 £110M £25M £18M 35p
Q3 2023 £120M £22M £16M 32p
Q4 2023 £95M £15M £10M 20p
6
Analysis
Up to Q3, revenue increased; however, in Q4, it decreased, which had an effect on operating and net profitability. In Q4, earnings per share declined as a result of decreasing competitiveness. The decrease in productivity might be ascribed to heightened competition or internal operational difficulties.
Strategy
GlaxoSmithKline (GSK)
Choosing to spend more on marketing in Q2 in order to increase sales.
Result: In Q2, revenue increased by €3.5 billion, while market share increased by 2%.
Competitors Analysis
Competitors Strategy Decision Result
Pfizer Increased R&D investment for new drug development in Q2. Launch of two successful drugs, leading to revenue growth of €4 billion.
AstraZeneca Expanded market presence in emerging markets in Q3. Revenue surge by €2.8 billion in Q3, gaining market share.
Johnson & Johnson Implemented cost-cutting measures in Q4. Marginal decrease in revenue due to reduced operating costs.
Marketing
GlaxoSmithKline (GSK)
Choosing: In Q3, a new product line was introduced.
Result: Positive consumer sentiment was reflected in market surveys, and Q3 revenue increased by €4.2 billion.
Competitors Analysis
Competitors Marketing Decision Result
Pfizer Aggressive marketing campaign for existing products in Q2. Revenue boost of €3.8 billion in Q2.
AstraZeneca Introduced innovative marketing strategies in Q3. Revenue growth of €3.5 billion in Q3.
Johnson & Johnson Revamped branding and packaging for key products in Q4. Market share growth in Q4.
HR
GlaxoSmithKline (GSK)
Conclusion: To lower attrition, education programs were put into place in Q1.
Result: Given industry trends, turnover decreased by 15% in Q1 and Q2, but increased by 5% in Q4.
Competitors Analysis
Competitors HR Decision Result
Pfizer Enhanced employee benefits in Q2. Reduced turnover by 12% in Q2 and Q3.
AstraZeneca Implemented flexible work policies in Q3. Marginal reduction in turnover in Q3.
Johnson
&
Johnson Invested in employee training and development in Q4. Stable turnover rates throughout the year.
Logistics
GlaxoSmithKline (GSK)
Decision: To cut expenses, logistics were outsourced in Q4.
The end result was an 8% decrease in cost of goods sold (COGS) in Q4, but quality problems surfaced that lowered customer satisfaction.
Competitors Analysis
Competitors Logistics Decision Result
Pfizer Consolidated distribution centers in Q3. Efficiency gains, reduced logistics costs.
AstraZeneca Streamlined supply chain operations in Q2. Improved delivery times and cost savings.
Johnson
&
Johnson Invested in state-of-the-art logistics technology in Q4. Enhanced supply chain efficiency.
Finance
GlaxoSmithKline (GSK)
Budget for R&D was lowered in Q4 in order to save expenses.
Reduced innovation has an effect on prospective economic prospects and competitive advantage.
Competitors Analysis
Pfizer Finance Decision Result
Pfizer Increased R&D spending for breakthrough research in Q2. Successful launch of new drugs, revenue growth.
AstraZeneca Implemented cost control measures in Q3. Maintained profitability despite challenges.
Johnson
&
Johnson Strategic acquisitions in Q4 for diversification. Revenue diversification, increased market presence.
Product Development
GlaxoSmithKline (GSK)
Decision: Postponed Q4 product introduction because of quality issues.
As a result, Q4 revenue and profit were lower, which had a bad effect on consumer impression.
Competitors Analysis
Competitors Product Development Decision Result
Pfizer Accelerated product development timelines in Q2. Successful launch, revenue growth.
AstraZeneca Invested in research for innovative products in Q3. New product lines, revenue increase.
Johnson
&
Johnson Launched product upgrades in Q4. Market share growth, positive reviews.
Responses to World Events:
GlaxoSmithKline (GSK)
Conclusion: In Q3, we promptly addressed supply chain interruptions.
Result: Showed resilience by maintaining income and profit in the face of difficulties.
Competitors Analysis
Competitors World Events Response Decision Result
Pfizer Implemented agile supply chain strategies in Q2. Managed disruptions, maintained profitability.
AstraZeneca Diversified sourcing options in response to geopolitical risks in Q3. Minimized supply chain impacts.
Johnson
&
Johnson Implemented contingency plans for natural disasters in Q4. Uninterrupted operations, minimal disruptions.
In Q2, GSK expanded its marketing budget carefully, which enhanced its market share and generated income. Pfizer's emphasis on research and development spending resulted in profitable new medicine releases. AstraZeneca's revenue growth was significantly fueled by its expansion into emerging markets. The cost-cutting initiatives of Johnson & Johnson improved efficiency in operations. The Q3 product line introduction by GSK was a great success, increasing revenue and improving consumer perception. Revenue was also increased by Pfizer's forceful marketing efforts and AstraZeneca's creative business plans. The branding initiatives of Johnson & Johnson resulted in a rise in industry share. GSK's training initiatives decreased turnover at first, but later experienced a little rise. Employee-centric efforts from Pfizer and AstraZeneca have been shown to regularly lower attrition. Because of its educational investment, Johnson & Johnson's turnover rates remained consistent. GSK's outsourcing initiatives reduced COGS, however there were issues with quality. The logistical improvements of Pfizer and AstraZeneca increased productivity and decreased expenses. Johnson & Johnson improved supply chain agility through their technological expenditures. The decrease in R&D expenditure by GSK had a detrimental effect on innovation. Pfizer launched successful products as a result of increasing its R&D spending. Cost-
cutting measures at AstraZeneca kept the company profitable. Strategic acquisitions by Johnson & Johnson increased revenue sources diversification(Hughes,2015).
5. Future Company Strategy
Innovation and Product Development
The company's approach to product development and innovation is centered on a large rise in R&D spending, indicating a dedication to promoting innovation and improving its range of products. The firm intends to stimulate the creation of innovative technologies, products, and solutions that may create competitive advantage and market differentiation by increasing R&D investment by 20%, from €50 million to €60 million. Simultaneously, an upbeat mindset to diversifying the product line is demonstrated by the intention to introduce five new goods in the following two quarters. The €8 million development expenditures invested in this program show an individualized resource management intended for quickly bringing new goods to market. Significant results are anticipated from these initiatives; estimates suggest an extra €30 million in revenue for the upcoming fiscal year. The new items' entry into the market, compatibility with consumer wants, market share acquisition, and possible creation of additional revenues are the main drivers of this revenue growth. All things considered, this plan shows an upbeat mindset to innovation, financial investment in potential future growth, and a calculated plan for improving the company's line of products and sources of income.
Market Expansion
Leverage prospects in 10 emerging markets with a combined projected market value of €500 billion is the company's goal in its global expansion plan. This calculated action shows a proactive strategy to taking advantage of large development prospects in high-potential areas. The firm has allocated €30 million for comprehensive market entrance strategy in order to enable effective market entry and penetration. The allocation includes strategic distribution methods to guarantee wide market coverage and client availability, and also customized marketing campaigns catered to the distinct qualities of each area. Within the following year, this campaign hopes to secure a significant 15% market share. This objective demonstrates the company's faith in the attractiveness of its products to these markets as well as its capacity to successfully compete and acquire traction against regional and international rivals. Through concentrating on growing its market share in these fast-growing areas, the company hopes to diversify its sources of income, become less dependent on any one market, and establish itself as a major force in important locations. The overarching objectives of market leadership, sustainable growth, and maximizing shareholder value are all in line with this approach (Van der Merwe,2013).
Operational Efficiency
The corporation uses a variety of tactics to optimize key areas of its operations as part of its strategic focus on operational efficiency. Fifteen automation projects that will be implemented in manufacturing and logistical activities are the focal point of this program. The long-term objective of these programs is to reduce operational expenses by 10% while also improving productivity and streamlining operations. These automation initiatives are expected to save €20 million in costs
annually, which represents a significant increase in cost effectiveness. The business is spending
€25 million on digital transformation projects to support the automation efforts. The purpose of
these investments is to improve the visibility and responsiveness of the supply chain by utilizing
cutting edge digital technology. The aim is to get a noteworthy 20% enhancement in supply chain
visibility metrics, which will allow the organization to more efficiently handle inventory, demand
variations,
and logistical obstacles in an anticipatory way. Furthermore, it is anticipated that the digital transformation
activities would result in observable practical advantages, such as a 15% lead time reduction and a 5%
improvement in on-time delivery. By guaranteeing prompt order fulfillment, these enhancements not solely increase
customer happiness but also save money by streamlining the logistics and inventory control procedures. All
things considered, the company's strategic emphasis on operational efficiency highlights its dedication to cost
reduction, ongoing improvement, and using technology as an instrument to boost competitiveness in the market and profitability(Hughes,2015)..
Financial Sustainability
A number of significant projects targeted at improving strategic investments, cutting interest costs, and
streamlining costs are included in the company's strategic approach to financial sustainability.
Process optimization and procurement methods are among the main areas of attention, with the aim of
finding cost-saving potential of €15 million.
The goal of these initiatives is to considerably reduce overall expenditures by 12%, which will greatly enhance financial performance and sustainability Simultaneously, 10% of the company's yearly revenue a crucial portion is being directed toward critical investments.
Important topics like market diversification tactics and technological advancements are included in these investments.
The corporation hopes to improve its competitive position, spur growth, and bolster its market presence in
specific categories by giving priority to these strategic expenditures. The company’s strategy change
includes a specific €20 million allotment for debt reduction or refinancing activities. This proactive
strategy guarantees an 8% reduction in interest expenditures over the specified term in addition to
optimizing the company's debt structure. The firm may strengthen its financial position, lower financial risks,
and increase its capacity to devote resources to value-creating projects and growth-promoting activities by
carefully controlling its debt and interest costs.
The corporation is adopting environmentally friendly sustainable practices by pledging to cut carbon emissions by 20%.
This includes a 25% increase in the use of clean energy and a 15% decrease in trash production. These programs show
the company's dedication to environmental stewardship and are in line with more general sustainability objectives.
The company's objective is to improve
Changes to Current Strategy
The corporation is making major changes to its strategy to better align it with the goals of sustainability and changing market dynamics. Reallocating 20% of the marketing budget to customer-centric efforts is one of the key adjustments. It's a strategy change that includes specific advertising efforts and loyalty program installation with the goal of increasing customer retention by 15% and increasing customer lifetime value by 10%. The ultimate goal of these initiatives is to increase brand loyalty, strengthen customer connections, and eventually provide steady revenue growth. The business is also aiming high in order to lessen its environmental impact. The organization is adopting environmentally friendly sustainable practices by pledging to cut carbon emissions by 20%. This includes a 25% increase in the use of clean energy and a 15% decrease in trash production. These programs show the company's dedication to environmental stewardship and are in line with more general sustainability objectives. The company’s objective is to improve
its standing as a conscientious business entity and achieve cost and operational efficiency by incorporating environmentally friendly procedures into its strategy.
Part B: Individual Reflective Report (Professional Development)
Introduction
This reflective report explores the lessons I learned and the experiences I had while actively engaging in the simulation team within the allotted time. The simulation was a great way for me to put the theoretical knowledge I learned in my MBA school into practice and gain direct experience with the complex operations of actual businesses. By means of strategic decision-making, market analysis, and cooperative teamwork in the simulation setting, I acquired real-world experience that enhanced my theoretical understanding. Two key simulation events will serve as the main focus of the study; these events were chosen because of their importance in influencing group dynamics, decision-making procedures, and leadership characteristics. I want to get important information and perspectives from these events analysis that will aid in my further career development. This introspective process has helped me get a deeper knowledge of company dynamics as well as pointing out places where my strategic thinking, decision-making, and leadership skills still need improvement. That introspective process has helped me get a deeper knowledge of company dynamics while also pointing out places where my strategic thinking, decision-making, and leadership skills still need improvement. Strategic R&D and product development initiatives as well as a thorough market growth plan are among the incidents being investigation. They had a significant impact on our team's methodology by highlighting possibilities, difficulties, plus the complexities of managing intricate business environments.
Identified Events
The choice of spending heavily in R&D in addition to product development was a single of the crucial moments throughout the simulation that had a big influence on our team's dynamics and strategic orientation. It proved to be an easy decision to make; instead it's the outcome of careful consideration, planned action, and analysis. A number of aspects were taken into account, such as internal strengths, rival activities, and market trends. The objective was to establish our business as a market leader in terms of innovative creations and adaptability to changing consumer needs.
projects, and coordinating R&D activities with market demands. The effective management of the complicated creation process while upholding quality standards also proved to be a major difficulty. To get past these obstacles, team members had to work closely together, communicate well, and adjust to changing conditions.
Outcomes Achieved
Numerous benefits resulted from the strategic investment in R&D and product development. First off, the team's capacity for invention was increased. Innovative concepts were conceived, investigated, and developed into concrete goods that filled holes in the market and catered to consumer demands. This investment directly led to the successful introduction of five cutting-edge products, all of which were well-received by consumers and enhanced brand recognition and client retention. Financially speaking, the decision's execution and strategic vision were demonstrated by the anticipated €30 million in added revenue.
Market Expansion Strategy
The creation and implementation of a thorough market growth plan was another noteworthy simulation event. The group set out on a strategic mission to identify and target 10 developing markets with a combined market value of €500 billion after seeing an opportunity for development in emerging economies. In order to secure a successful entry and long-term growth in those sectors, this choice necessitated thorough analysis, market research, and strategic planning.
Key Decisions
A calculated decision was taken to choose and focus on 10 rapidly expanding emerging markets, which together account for an incredible €500 billion market. a sizeable €30 million budget was set up for focused market entrance tactics with the goal of gaining a competitive 15% market share.
This choice was supported by in-depth competition comparisons, market analysis, and a profound comprehension of the subtle cultural and economic differences in every targeted area. In order to create strategies that were specific to each market, teams from marketing, sales, and operations had to collaborate across the lines of function(Hughes,2015).
Challenges Faced
Market growth presented a variety of difficulties. First of all, it was difficult to fully comprehend the many factors that are present in every target market. Across markets, there were notable differences in the legislative framework, customer preferences, competitive landscape, and distribution routes. Developing methods to successfully localize operations, modifying goods and services to suit regional demands, and building a strong competitive presence in unexplored markets were the main obstacles encountered. Further difficulties included providing uniform brand message, minimizing hazards related to worldwide growth, and successfully handling resources across regions.
13
marketplaces improved our team's proficiency in cross-border company administration, cultural adjustment, and long-term planning(Van der Merwe,2013)..
Conclusion
In summary, the events of strategic investment in R&D/product development and market growth that were highlighted were life-changing experiences that influenced our ability to work as a team, make decisions, and lead others. The aforementioned incidents emphasized the significance of strategic planning, cross-functional cooperation, flexibility, and ongoing education in attaining prosperity for businesses. These encounters have been extremely beneficial to my career growth on an individual basis. My future professional aspirations will benefit greatly from the newfound understanding I have of risk management, market analysis, strategic decision-making, and multinational company tactics. Thinking back on these experiences has improved my comprehension of concepts in theory and given me useful perspectives on how they may be used in the real world, all of which have contributed to my development as a more capable and astute business professional.
Application of Theory and Practice
Strategic Investment in R&D
and Product Development
Theory Application
The incident is in line with theories of tactical leadership, especially those that emphasize the distribution of resources and innovation-driven tactics. According to the Resource-Based View (RBV) theory, valuable, scarce, and unique resources are the source of long-term competitive advantage. In addition to RBV, Dynamic Capabilities Theory emphasizes how crucial it is for companies to reconfigure, and adjust their resources in response to shifting surroundings. The decision to boost R&D spending from €50 million to €60 million in this setting may be understood as a strategic move aimed at strengthening the company's base of resources and creating new capabilities that will contribute to prolonged competitive.
Relevance and Validity
Such applied ideas, which highlight the need of ongoing innovation and efficient resource use in promoting sustainable growth and competitive resilience, are still very relevant and useful today. The company uses its own capabilities to develop novel goods, solidify its position in the market, and maintain a competitive edge over time by making smart R&D investments.
Numerical Comparison
• Original R&D Investment: €50 million
• Increased R&D Investment: €60 million
• Number of New Products Launched: 5
• Expected Additional Revenue: €30 million
Market Expansion Strategy
14
Theory Application
International business theories, particularly those that clarify market entrance tactics and worldwide growth frameworks, are in line with the market expansion plan. According to the Uppsala Model, businesses progressively expand their commitment to international markets as a result of experiential learning and market awareness. When it comes to the ownership, location-specific, and internalization benefits of expanding into new markets, the Eclectic Paradigm also referred to as the OLI Framework helps businesses make well-informed decisions.
Relevance and Validity
These ideas are highly relevant and valid, providing solid foundations for managing the challenges of entering and making a name for oneself in a variety of international marketplaces. In line with the theoretical underpinnings of international business, the strategic investment of €30 million for market entrance strategies represents a methodical approach to market selection, entry mode decisions, and localization plans.
Numerical Comparison
• Market Size of Targeted Emerging Markets: €500 billion
• Budget Allocated for Market Expansion: €30 million
• Target Market Share: 15%
Justification and Analysis
A proactive attitude to strengthening the company's innovative capabilities is indicated by the rise in R&D spending from €50 million to €60 million. Since the company strategically uses its resources to develop a sustained competitive advantage via innovation, this is consistent with RBV and Dynamic Capabilities Theory. The successful implementation of this strategic investment is confirmed by the introduction of five new items and the anticipated €30 million in increased income. In a similar vein, the company's intention to take advantage of developing market prospects is reflected in the market expansion plan. The market entrance initiatives that received €30 million show a deliberate approach to market selection and localization, informed by theories like the Diverse Paradigm and the Uppsala Model. The company's aspirations and strategic positioning in international markets are demonstrated by the projected 15% market share aim. In summary, the firm's intentional acts, numerical data, and anticipated results clearly demonstrate the application of theory and practice in strategic investment in R&D/product development and market growth plan. Through adherence to recognized theories and the utilization of numerical data for comparative analysis, the organization optimizes its capacity for long-term growth and competitive advantage while also strengthening its strategic decision-making skills.
Discussion and Recommendations
Professional Development Review
My awareness of market analysis methods, methods for making strategic choices, and the subtleties of successful teamwork has expanded significantly as a result of the simulation
experience. I improved my analytical and strategic thinking abilities by learning how to handle challenging business scenarios and gaining insights into real-world issues through the simulation.
Recommendations for Improvement
Continued Skill Enhancement
International Business Strategies: The simulation emphasized the significance of the dynamics of
the world market. I intend to engage in advanced courses or workshops that concentrate on international business strategies in order to further develop my skills in this area.
Negotiation Prowess: In commercial transactions, having strong negotiating abilities is essential.
By taking part in negotiation seminars or simulations, I may improve my capacity to reach
mutually beneficial agreements and hone my negotiating skills.
Expert Project Management: Managing intricate projects requires a strong set of project management abilities. My ability to design, carry out, and oversee projects will increase if I pursue project management certifications or training courses.
Improving Practice
Culture of Continuous Learning: Promoting a culture of continuous learning within the team might help to create new ideas and skills. Regular training sessions, knowledge-sharing websites, and mentorship initiatives may encourage lifelong learning and career development.
Cross-Functional Collaboration: Innovation and synergy are increased when departments work together. Starting cross-functional task forces or projects may promote teamwork, enhance interaction, and encourage collaborative problem-solving.
Leadership Development: Funding programs for leadership development can help a team's members strengthen their leadership abilities. Coaching sessions, mentoring programs, and leadership courses can enable people to assume leadership responsibilities with effectiveness.
Numerical Figures and Impact
International Business Strategies
Enhancing market insights and strategic decision-making ability requires funding advanced courses or seminars on foreign company strategies. A budget of €10,000 indicates a dedication to gaining the specific knowledge and abilities required to navigate international markets. An important gain in awareness of foreign markets is part of the expected profit on expenditures, since this helps to improve global competitiveness and create more successful corporate development plans.
Negotiation Prowess
In commercial transactions, having strong negotiating abilities is essential.
Enhancing one's negotiating abilities may be achieved by investing in a negotiation simulation workshop, which is projected to cost €5,000. This investment has significant potential returns, including the capacity to close better agreements, cut costs by skillful negotiating, and fortify commercial ties. Improved negotiating skills are a great asset that influence company results and help an organization succeed as a whole.
Expert Project Management
Devoting €8,000 to obtaining a project management certification signifies a deliberate effort to enhance project scheduling, execution effectiveness, and delivery schedules. This investment has the potential to provide better project outcomes, higher levels of customer satisfaction, and increased organizational performance. Proficiency in project management is important for effectively overseeing intricate endeavors and guaranteeing project triumph inside designated budget and schedule constraints (Van der Merwe, 2013).
Initiatives for Continuous Learning
Setting aside €15,000 for seminars and training sessions on pertinent business subjects every three months shows a dedication to ongoing education and skill improvement. Increased information exchange, improved skill sets among team members, and an organizational culture of continuous development are all included in the effect evaluation of this investment. Initiatives for continuous learning encourage creativity, strengthen problem-solving skills, and support professional development for both individuals and organizations.
Collaboration Across Functions
Devoting €20,000 to a cross-functional project effort shows a deliberate commitment to encouraging innovation and cooperation between departments. Improved departmental communication, more project execution synergy, and quicker problem-solving skills are all anticipated outcomes. For the purpose of fostering creativity, using a variety of specialties, and accomplishing group objectives that support organizational success, cross-functional cooperation is crucial.
Leadership Development Programs
The €12,000 budgeted for a series of mentoring sessions and seminars focuses on enhancing decision-making skills and cultivating leadership traits. Initiatives for leadership development have the potential to empower next leaders and increase performance among teams and organizations. Leadership development programs play a pivotal role in creating a robust pipeline of future leaders, propelling strategic endeavors, and cultivating an exceptional culture inside the business.
To summarize, the enhancement of individual and team competencies necessitates strategic investments in professional development areas such as international business strategies, negotiating skills, project management, continuous learning, cross-functional cooperation, and growth in leadership. In fast-paced corporate settings, these investments not only foster development but also help achieve success and sustained growth. Proactively pursuing organizational and personal growth puts us in a position to succeed in the long run and remain competitive in the rapidly changing global market.
17
Structure and Writing
The report's methodical format reflects our organization's preference for a systematic approach.
The text is rationally and harmoniously flowed since each segment is well defined. The official tone used upholds a professional manner, demonstrating the gravity with which we treat our analysis and suggestions.
The goal of the report and the events that are being examined are briefly explained in the introduction. This prepares the groundwork for a thorough examination of the highlighted occurrences, including the market expansion plan and the calculated investment in R&D and manufacturing. The report's methodical format reflects our organization's preference for a systematic approach. The text is rationally and harmoniously flowed since each segment is well defined. The official tone used upholds a professional manner, demonstrating the gravity with which we treat our analysis and suggestions. The goal of the report and the events that are being examined are briefly explained in the introduction. This prepares the groundwork for a thorough examination of the highlighted occurrences, including the market expansion plan and the calculated investment in R&D and manufacturing. The Resource-Based View (RBV) and Dynamic Capabilities Theory are two theories that are skillfully used to the study of the events in order to provide insight into the strategic choices that were taken. These ideas are shown to be genuine and relevant, highlighting their usefulness in actual situations (Hughes, 2015).
The ramifications of these events for professional growth are explored in detail in the discussion section. The simulation experience has given us great insights into market analysis, teamwork, or strategic decision-making-all of which are essential for professional development in our firm. The suggestions made are designed to improve abilities in leadership, project management, negotiation, and international business methods. These suggestions are supported by hard data that shows the necessary investment and anticipated return on investment, so they are not only theoretical. An allocation of €10,000 towards courses on international business strategy is anticipated to result in enhanced market insights and strategic competencies, hence immediately enhancing firm development initiatives. The report's writing style and structure are intended to guarantee cohesion and clarity. Every part flows into the next with ease, creating an engaging story that is backed up by data and research. The insights are given more respect when a formal tone is used, which is consistent with our organization's standards for accuracy and professionalism. Overall, the report's disciplined methodology, official writing style, and evidence-based analysis demonstrate our dedication to accuracy and quality in all that we do.
18
Appendix
Individual Reflection Logs
First quarter of 2023:
Our team made important choices this quarter on where to strategically invest in R&D and product development. I actively participated in the deliberations and analysis that resulted in the decision to raise R&D spending by 20% as a team member. As part of my job, I looked into market trends, evaluated competitive environments, and added to the financial data that backed this calculated decision. Managing with several departments to expedite the development process and guaranteeing alignment between increasing investment and projected returns were among the challenges faced.
Second quarter of 2023:
This quarter, we saw a gain in revenue and market share, which demonstrated the impact of our strategic initiatives. My responsibilities have expanded to include keeping an eye on the results of our R&D expenditures, examining consumer input on new items, and helping to assess marketing tactics. Difficulties continued, especially with regard to cost structure optimization and resolving quality issues in product development. Nonetheless, the fruitful outcomes validated our team's strategic orientation and cooperative endeavors.
Third quarter of 2023:
Our team encountered fresh possibilities and problems as the year went on. We increased our market presence, introduced new goods with success, and upheld our excellent brand reputation. My responsibilities have broadened to encompass market research in developing areas, evaluating the success of our advertising initiatives, and participating in plans to maintain client happiness. In order to support our growth ambitions, challenges included improving operational efficiency and adjusting to varied market circumstances.
Fourth quarter of 2023:
Issues with quality and dwindling income surfaced in the last quarter, necessitating quick fixes and tactical alterations. As part of my job, I had to investigate the underlying causes of quality problems, work with cross-functional groups to resolve supply chain interruptions, and participate in talks about how to remain financially stable in the face of market volatility. Despite difficulties, the quarter taught important lessons about strategic pivoting, crisis management, and the value of ongoing progress.
19
reflection:
I learned more about cross-functional cooperation, market dynamics, and strategic decision-making during the simulation. My capacity to make decisions, think analytically, and adjust to changing business situations has all improved as a result of the simulation. As I think back on these experiences, I see places where I may grow personally, such as strengthening my skills in financial analysis, developing crisis response plans, and honing my communication among various teams. This introspective process has greatly influenced how I comprehend strategic management concepts and how to use them practically in everyday situation.
References
• Van der Merwe, N., 2013. An evaluation of an integrated case study and business simulation to develop professional skills in South African accountancy students.
• Hughes, S. and Scholtz, F., 2015. Increasing the impact of a business simulation: The role of reflection. The International Journal of Management Education, 13(3), pp.350-361.
• Levant, Y., Coulmont, M. and Sandu, R., 2016. Business simulation as an active learning activity for developing soft skills. Accounting Education, 25(4), pp.368-395.
• Léger, P.M., Charland, P., Feldstein, H.D., Robert, J., Babin, G. and Lyle, D., 2011. Business simulation training in information technology education: guidelines for new approaches in IT training. Journal of Information Technology Education: Research, 10(1), pp.39-53.
• https://www.gsk.com/en-gb/company/
20
21